Generally Covered: Diabetes indication with documented A1C elevation Generally Not Covered: Obesity alone without diabetes or other qualifying conditions Private Insurance: Coverage varies widely by plan, some cover weight management medications Research Peptides: Not covered by any provincial plan or private insurance (personal expense) Regional Access to Research Peptides Domestic Canadian shipping eliminates regional access disparities for research peptides
Both medications were tested in large clinical trials with thousands of people who didnt have diabetes
Ultimately, the ideal diet while on GLP-1 medications varies depending on individual preferences and metabolic responses
In this guide, well explore practical strategies for enhancing GLP-1 levels with higher satiety and nutrient-dense foods
- Pipeline shift: Pharma companies are moving away from traditional therapies and investing more into multi-agonist therapies such as GLP-1/ glucagon, GLP-1/Gastrin to achieve high efficacy with minimum toxicity
Laboratory studies have explored its role in: Cell culture and proliferation assays Molecular binding and receptor interaction studies Tissue regeneration and wound healing models Biochemical pathway analysis Pharmacokinetic and stability profiling Note: GLP-3RT sold by CoreVionRX is intended strictly for research purposes
